Jeff's practice focuses in the areas of securities regulation, corporate financing, mergers and acquisitions, and corporate governance for a variety of private and publicly held clients. He leverages experience in private practice and as deputy general counsel for an international, publicly traded medical device company to drive growth for clients.

Jeff has represented numerous companies and investment banks in connection with billions of dollars in securities offerings, including IPOs, secondary offerings, registered direct offerings, Rule 144A offerings and foreign offerings. Recent transactions include representing:

The Spectranetics Corporation in its convertible debt offering
The Spectranetics Corporation in its secondary common stock offering
tw telecom in its 144A debt offerings, public debt offerings and common stock offerings
Ascent Solar in its secondary public offering
Crocs in its IPO and secondary offering
A mine development company in its secondary offering
A commercial printing company in a series of 144A offerings of debt securities and exchange offers
StarTek, Inc. in its secondary public offering
Displaytech in its IPO
The underwriters in initial and seasoned issuer public offerings for companies in the biosciences, software, food, heavy manufacturing, automation and entertainment industries

Jeff also counsels public companies in connection with going private transactions, issuer tender offers for debt and equity, accelerated stock repurchases, and other security purchase programs.